Combinations for the treatment of diseases involving cell proliferation

Details for Australian Patent Application No. 2005274384 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Munzert, Gerd; Baum, Anke; Steegmaier, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2005274384

PCT Pub. Number WO2006/018182

Priority 04019361.7 14.08.04 EP; 04019448.2 17.08.04 EP

Filing date 9 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 23 June 2011

International Classifications

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

29 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018182 Priority application(s): WO2006/018182

23 June 2011 Application Accepted

  Published as AU-B-2005274384

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274387-Dihydropteridinones for the treatment of cancer diseases

2005274377-Method of screening for a carnitine transporter agonist or antagonist and its uses